Table 2.
Odds ratios (95% CIs) for the associations of sleep duration (n = 2007) and insomnia symptoms (n = 2068) with a moderate to high aMed diet score at Exam 5
| aMed score† | Sleep duration‡ (reference: <6 hr/night) |
Insomnia symptoms§ (reference: no insomnia) |
||
|---|---|---|---|---|
| 6 to <7 hr/night n = 640 |
7–8 hr/night n = 532 |
>8 hr/night n = 226 |
Insomnia n = 739 |
|
| Moderate-high aMed score (≥5) | ||||
| Model 1 | 1.30 (1.03, 1.63)* | 1.05 (0.82, 1.34) | 0.83 (0.60, 1.14) | 0.81 (0.67, 0.97)* |
| Model 2 | 1.32 (1.05, 1.66)* | 1.05 (0.82, 1.34) | 0.84 (0.61, 1.16) | 0.81 (0.68, 0.98)* |
| Model 3 | 1.38 (1.07, 1.78)** | 1.05 (0.80, 1.38) | 0.97 (0.68, 1.40) | 0.82 (0.67, 1.00) |
| Model 4 | 1.43 (1.08, 1.88)** | 1.05 (0.78, 1.40) | 0.95 (0.64, 1.42) | 0.85 (0.68, 1.06) |
†Reference= low aMed score (<5).
‡For sleep duration (ref <6 hr, n = 609).
§For insomnia symptoms (ref no insomnia symptoms, n = 1329).
MODEL 1: adjusted for age, gender, race/ethnicity.
MODEL 2: adjusted for covariates in Model 1 as well as education.
MODEL 3: adjusted for covariates in Model 2 as well as cigarette smoking, intentional exercise, and total energy intake (Kcal/day).
MODEL 4: adjusted for covariates in Model 3 as well as, body mass index (Kg/m2), hypertension, diabetes, depressive symptoms (CESD score ≥ 16), AHI (continuous), insomnia symptoms, antidepressants and anti-psychotic medication.
In the models with insomnia symptoms as main predictor, we also adjusted for sleep duration (hr) in the last model.
*p < 0.05; **p ≤ 0.01. Bold values indicate significance.